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Epidural anesthesia (EA) has been used for endo-
luminal abdominal aneurysm repair (EAAR).1-3 The
relatively low invasiveness of the endovascular proce-
dure, the absence of laparotomy, and the consequent
reduction of surgical stress are optimal conditions for
the use of EA. Concomitantly, prospects of further
decreasing the invasiveness of the procedure, of
extending the surgical indication to high-risk patients,
in particular those with severe chronic obstructive
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Purpose: The low invasiveness of endoluminal abdominal aneurysm repair (EAAR)
appears optimal for the use of epidural anesthesia (EA). However, reported series on
EAAR show that general anesthesia (GA) is generally preferred. To evaluate the feasi-
bility and problems encountered with EA for EAAR, patients undergoing EAAR with
EA and patients undergoing EAAR with GA were examined.
Methods: From April 1997 through October 1998, EAAR was performed on 119
patients at the Unit of Vascular Surgery at Policlinico Monteluce in Perugia, Italy. Four
patients (3%) required conversion to open repair and were excluded from the analysis
because they were not suitable candidates for evaluating the feasibility of EA. The study
cohort thus comprised 115 patients undergoing abdominal aortic aneurysm (AAA)
repair with the AneuRx Medtronic stent graft. The incidence of risk factors and anatom-
ical features of the aneurysm were compared in patients selected for EA or GA on the
basis of intention-to-treat analysis. Intraoperative and perioperative data were compared
and analyzed on the basis of intention-to-treat and on-treatment analysis.
Results: Sixty-one patients (54%) underwent the surgical procedure with EA (group A),
and 54 (46%) underwent the surgical procedure with GA (group B). Conversion from
EA to GA was required in four patients (3 of 61 patients, 5%). There were no statisti-
cally significant differences between the two study groups in demographics, clinical
characteristics, and American Society of Anesthesiology classification (ASA). There was
no perioperative mortality. Major morbidity occurred in 3% of patients (group B).
According to intention-to-treat analysis, no significant differences were observed
between the two groups in mean operating time, fluoro time, blood loss, amount of
contrast media used, mean units of transfused blood, need of intensive care unit, mean
postoperative hospital stay, and postoperative endoleak. Conversely, significant differ-
ences were found by means of on-treatment analysis in the need of intensive care unit
(0 vs 5 patients; P = .02), and length of hospitalization (2.5 vs 3.2 days; P = .04).
Multivariate logistic regression analysis showed that GA and ASA 4 were positive inde-
pendent predictors of prolonged (more than 2 days) postoperative hospitalization (haz-
ard ratio, 2.5; 95% CI, 1.1 to 5.8; P = .03, and hazard ratio, 5.1; 95% CI, 1.5 to 17.9;
P = .007, respectively).
Conclusion: EA for EAAR is feasible in a high percentage of patients in whom it is
attempted, and it ensures a technical outcome comparable with that of patients under-
going EAAR with GA. Successful completion of EAAR with EA is associated with a
short period of hospitalization. (J Vasc Surg 1999;30:651-7.)
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pulmonary disease (COPD), and of possible cost-sav-
ings hold great appeal for EA. Nevertheless, reported
series on EAAR show that general anesthesia (GA) is
preferred in most cases.2-8 The surgeon feels more
comfortable operating on a sleeping, anesthetized
patient, who may undergo any exacting procedure
without disturbing the operating field and the surgi-
cal team. To examine these issues and determine
problems encountered with EA for EAAR, patients
undergoing EAAR with EA and patients undergoing
EAAR with GA were studied. 
PATIENTS AND METHODS
From April 1997 through October 1998, 242
patients underwent elective abdominal aortic
aneurysm (AAA) repair; 119 (49%) of these
patients received EAAR, all with the same type of
device, and they represent the cohort of the pre-
sent study. Ten patients underwent EAAR before
the study period; these patients were not included
in our report, because they represent our learning
curve. In addition, these 10 patients underwent
EAAR with a different device, and we intended to
analyze patients undergoing the procedure with
the same type of graft.
Data from patients selected to undergo EAAR
were entered in a database. Demographics, risk fac-
tors, type of diagnostic examinations performed,
anatomic features, and anesthesiological, intraoper-
ative, and follow-up data were recorded. In the first
15 cases, EA was not attempted. Subsequently, all
patients were considered possible candidates for
EA, and the choice of anesthesia was left to the dis-
cretion of the anesthesiologist. All patients under-
went endovascular exclusion of the AAA with a
modular Dacron bifurcated endograft covered by 
an externally supported nitinol stent (Medtronic
AneuRx; Sunnyvale, Calif). Four patients (3%)
required immediate conversion to open repair. In
two cases, conversion was caused by access prob-
lems through the iliac vessels; in one case, conver-
sion was caused by the inability to insert the con-
tralateral limb into the main body of the endograft;
and in one case, conversion was caused by endograft
misplacement. One of the four patients was operat-
ed on with EA and was converted to GA to under-
go open repair. The converted cases were not suit-
able for evaluating the feasibility of EA and were
therefore excluded from the present analysis, leav-
ing the study cohort comprising 115 patients. The
mean age of the patients was 69.8 ± 7 years (range,
51 to 86 years); 105 patients (91%) were men. The
mean follow-up period was 4.7 months (range, 1 to
14 months). Overall, 56 of the 115 patients had a
6-month follow-up period; 23 of them underwent
EAAR with EA and 33 underwent EAAR with GA.
The operation was carried out in an operating
room by a team of vascular surgeons and interven-
tional radiologists. Before discharge, assessment of
correct positioning of the endograft and verification
of complete exclusion of the AAA were evaluated by
means of plain abdominal radiographs and colorflow
duplex scanning. 
All patients in the present study were anesthetized
by the same anesthesiologist (A.S.). Patients received
a standard premedication of 5 to 10 mg of diazepam
orally 90 minutes preoperatively. The anesthesiologist
selected patients for EA or GA. Selection was gener-
ally based on the patients’ preference. However, in the
case of severe COPD, EA was advised. A nasogastric
tube was not introduced in patients undergoing the
procedure with EA or in those undergoing the proce-
dure with GA. 
EA was performed by placing an epidural catheter
at the L2-L3 level. An epidural block was then per-
formed, giving a loading dose of 10 mL of 0.5% bupi-
vacaine or 10 mL of 0.75% ropivacaine, associated
with mild sedation with LV midazolam (2 to 4 mg).
The intent of the anesthesiologist was to sedate
patients at a Ramsay level 2 (“cooperative, oriented,
and tranquil”).9 Inadequate pain control was treated
with further loading until the desired analgesia (at the
level of T10) was achieved. 
Patients in the GA group had an anesthetic
induction with 2 to 3 mg of midazolam, 2 to 3
µg/kg of Fentanyl, 0.5 to 1 mg/kg of propofol, and
0.1 mg/kg of vecuronium to facilitate tracheal intu-
bation. Anesthesia was maintained with a low flow
(less than 1 L) mixture of N2O and oxygen (FIO2 =
0.4), 1.2% to 1.6% sevoflurane end-tidal, and addi-
tional vecuronium to sustain paralysis as required.
Both groups were given a bolus of mannitol (0.5 to
1 g/kg) to protect renal function. 
In the operating room, all patients were moni-
tored in a similar fashion, with a three-lead electro-
cardiogram (CS5) and sinus tachycardia analysis and
monitoring of invasive and noninvasive blood pres-
sure, arterial hemoglobin oxygen saturation, and
body temperature. In the GA group, ETCO2 was also
monitored. Heparin was administered before clamp-
ing the femoral arteries (100 U/kg) and was reversed
with protamine at the end of the procedure (1
mg/100 units of heparin). In patients undergoing the
procedure with EA, the hemostatic profile was
checked 24 hours after the procedure, and if the find-
ings were normal, the epidural catheter was removed.
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Transfer of the patient to the intensive care unit
after surgery was left to the discretion of the anesthe-
siologist. In both groups, postoperative pain was
managed with nonsteroidal anti-inflammatory drugs.
When no complications were present (ie, transfer to
the intensive care unit), a regular diet was resumed on
the first postoperative day. 
Abnormal refilling of the aneurysm after endo-
grafting, evident by means of a duplex or computed
tomography (CT) scan, was defined as an endoleak.
An endoleak was defined as immediate when it was
detected in the immediate postoperative period and as
graft-related when it was caused by imperfect adhe-
sion of the endograft at the level of the proximal or
distal aortic necks or at the graft-to-graft junction.
Endoleaks generated by continued perfusion of the
aneurysm sac by patent branch arteries, such as the
inferior mesenteric artery or lumbar arteries, were
defined as reperfusion endoleaks. The endoleak classi-
fication by White was used.10 In the case of endoleaks
that were thought not to be related to reperfusion
from the inferior mesenteric artery or lumbar arteries
(graft-related endoleaks), a contrast-enhanced CT
scan or an arteriogram was performed before dis-
charge. Duplex and CT scans, plain abdominal radi-
ography, and clinical evaluation were repeated 1, 6,
and 12 months after surgery and annually thereafter. 
The incidence of risk factors and anatomical fea-
tures of the aneurysm were compared between
patients selected to undergo EA and GA on the basis
of intention-to-treat analysis. Intraoperative data
(operating time, fluoro time, blood loss, amount of
transfused blood, amount of contrast media used)
and perioperative data (duration of intensive care
unit stay and hospitalization, incidence of major
complications) were compared and analyzed on the
basis of intention-to-treat and by considering the
type of anesthesia actually received (on-treatment
analysis). Finally, considering that EA enables the
patient to move on the operating table, potentially
compromising the exactness of the endovascular
procedure, the use of proximal cuffs and the inci-
dence of immediate graft-related endoleaks were
also compared.
Risk factors, operative data, and clinical parame-
ters of patients were compared and analyzed by means
of χ2 test (Mantel-Haenszel and Yates corrected),
analysis of variance, and Kruskal-Wallis tests. Stepwise
multivariate logistic regression analysis was used to
identify independent predictors of the need for time
in the intensive care unit and length of hospitaliza-
tion. Variables examined for their influence on the
need for time in the intensive care unit and prolonged
hospitalization were sex, COPD, AAA diameter of 5
cm or more, aneurysm class (A or B, according to the
Eurostar protocol11), aortic neck angulation more
than 90 degrees, circumferential iliac calcifications,
American Society of Anesthesiology (ASA) class 4,12
and GA. Variables were considered statistically signif-
icant at P level of .05 or less.
RESULTS
Demographic, clinical characteristics, ASA classi-
fication, and anatomic features of patients selected
to undergo the operation with EA or GA were well
balanced in the two study groups (Tables I and II). 
Sixty-one patients (54%) underwent the endovas-
cular procedure with EA (group A); 54 patients (46%)
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Table I. Demographics, risk factors, and American Society of Anesthesiology classification in 115 patients
Epidural anesthesia (n = 61) General anesthesia (n = 54)
Number % Number % P value
Mean age (years) 69.3 ± 7.1 70.3 ± 7.0 .3
Smoking 15 24 18 33 .4
Hypertension 34 56 33 61 .7
Diabetes mellitus 7 11 6 11 .8
Hypercholesterolemia 8 13 4 7 .5
Peripheral vascular disease 11 18 5 9 .3
Coronary artery disease 28 46 24 44 1
Cerebrovascular disease 6 10 5 9 .8
COPD 29 47 24 44 .9
Renal insufficiency 6 10 5 9 .8
ASA classification II 8 13 3 5
ASA classification III 44 72 43 80 .4
ASA classification IV 9 15 8 15
*Previous myocardial infarction, angina, or electrocardiographic evidence of myocardial ischemia. 
underwent the endovascular procedure with GA
(group B). No cases were canceled because a “bloody
tap” epidural precluded administration of heparin. In
three of the 61 patients (5%), conversion from EA to
GA was required. Causes of conversion to GA includ-
ed patient intolerance and anxiety in two cases and
insufficient analgesia in one case, in which an extraperi-
toneal approach to the iliac arteries was required. All
patients in whom EA was used were mobilized and
resumed a regular diet on the first day after implanta-
tion. Five patients (6%) in group B were transferred
after surgery to intensive care, four for difficult wean-
ing and one for hemodynamic instability. There was no
perioperative (30 days) mortality. Major perioperative
morbidity occurred in three of the 115 patients (3%)
and included a nondisabling stroke during a secondary
endovascular procedure (this patient had a brachial
wire), an occlusion of the endograft limb 27 days post-
operatively that warranted a femoral-femoral bypass
grafting procedure, and a renal infarction caused by
covering of the right renal artery by the endograft,
treated with a nephrectomy. All major complications
occurred in group B. Inadvertent covering of the
hypogastric artery occurred in four patients (three in
group A and one in group B). Late death caused by
pulmonary embolism after orthopedic surgery
occurred in one patient in group B (1%).
Endoleaks were detected in the immediate post-
operative period in 18 patients (16%); 11 were reper-
fusion endoleaks, and seven were graft-related
endoleaks (four in patients in group A and three in
patients in group B; P = 1). At 6 months, three graft-
related and four reperfusion endoleaks persisted.
Operative and postoperative data, according to
intention-to-treat and on-treatment analysis, are
reported in Tables III and IV, respectively. 
Multivariate analysis showed that GA and patient
classification ASA 4 were positive independent pre-
dictors of prolonged (more than 2 days) hospitaliza-
tion (hazard ratio, 2.5; 95% CI, 1.1 to 5.8; P = .03
and hazard ratio, 5.1; 95% CI, 1.5 to 17.9; P = .007,
respectively).
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Table II. Anatomic features of 115 patients
Epidural anesthesia (n = 61) General anesthesia (n = 54)
Number % Number % P value
Mean AAA diameter (mm) 48.5 49.7 .5
Angulation of proximal aortic 
neck < 150 degrees 11 18 14 26 .4
Angulation of aortic bifurcation 
> 90 degrees 1 2 3 5 .3
Anular aortic calcification 0 3 5 .1
Anular iliac calcification 14 23 14 26 .9
Eurostar classification A 10 16 6 11
Eurostar classification B 33 54 38 70
Eurostar classification C 7 11 4 7 .5
Eurostar classification D 5 8 2 4
Eurostar classification E 6 10 4 7
AAA, Abdominal aortic aneurysm.
Table III. Operative and perioperative data of 115 patients (intention-to-treat univariate analysis)
Epidural anesthesia (n = 64) General anesthesia (n = 54) P value
Mean operating time (minutes) 124 125 .6
Mean contrast agent (mL) 157 159 .9
Mean fluoro time (minutes) 21.6 22.7 .8
Mean blood loss (mL) 286 282 .8
Mean units of transfused blood 0.13 0.28 .07
Patients transferred to ICU 1 4 .18
Mean postoperative hospital stay (days) 2.6 3.2 .18
Proximal cuffs 4 4 1
Postoperative endoleaks 9 9 1
Graft-related endoleaks at 30 days 2 4 .4
ICU, Intensive care unit.
DISCUSSION
EAAR usually requires a small bilateral groin
incision for exposure of the femoral arteries, which
appears to be ideal for the use of EA. There is little
information about how the type of anesthesia influ-
ences the outcome of endovascular surgery. Despite
the potential benefits derived from the use of EA in
patients undergoing endoluminal replacement of
aortic aneurysms, there are few studies available on
this issue, and reported series on endografting show
that GA is used in most patients.1-8 
There are many reasons why GA is commonly
favored in patients undergoing EAAR. In the so-
called learning-curve phase, GA is generally preferred,
because conversion to open repair is potentially more
frequent and the surgeon feels more comfortable
operating on a sleeping patient. Likewise, in the initial
phases, EAAR usually requires more time than the
standard surgical approach, and the patient may
become fatigued by maintaining the same position
throughout the operation. Early in our experience, we
used GA, and only when we became more accus-
tomed to the endovascular procedure did we use EA.
An analysis of the possible repercussions of an awake
patient on the technical outcome was performed, and
no substantial differences were found between the
two study groups in the exactness of implantation,
measured by means of proximal cuffs, and the inci-
dence of postoperative graft-related endoleaks. With
deep sedation, the patient is motionless, and the pro-
cedure with EA can be virtually identical to that with
GA. However, we consider the possibility of working
with a collaborating patient to be an advantage of EA.
In the attempt to achieve the most precise positioning
of the endograft, we routinely ask patients to hold
their breath during imaging acquisition. In addition,
it might be helpful to monitor the patient’s possible
symptoms (eg, sudden abdominal or back pain). On
the other hand, during the deployment phase, a
patient moving even millimeters may compromise the
correct positioning of the endograft.
In the early years, aortic endovascular replacement
was considered to be the treatment of choice for
elderly, high-risk patients.2,13-15 In this category of
patients, it is reasonable to assume that EA may help
prevent postoperative complications, provided that
these patients have appropriate anatomical features to
minimize the risk of conversion to open repair. Two
studies demonstrated better surgical outcome with
EA in high-risk patients undergoing major vascular
surgery. They found lower rates of mortality, cardiac
failure, infectious complications, and overall postoper-
ative complications in patients given EA and postop-
erative EA compared with those given GA and post-
operative parenteral analgesia.16,17 
In our series, high-risk patients were equally dis-
tributed in the two study groups. Indeed, recent
experiences in selected centers have shown that EAAR
is proposed when applicable to all patients with AAA,
and the average surgical candidate is a good-risk
patient with suitable anatomical features.4,8 At our
institution, endovascular repair is performed on
approximately 50% of patients referred to our unit for
AAA. The use of EA is appealing, not only because it
potentially minimizes perioperative complications,
but also because it lowers the invasiveness of the pro-
cedure, permitting a shorter hospital stay and con-
tainment of expenses, thus changing even more dra-
matically the nature of abdominal aortic surgery.
Indeed, the use of GA was shown by means of on-
treatment multivariate analysis to be a positive inde-
pendent predictor of prolonged hospitalization in
patients undergoing EAAR. These findings were not
confirmed by means of intention-to-treat univariate
analysis (Table III), by which patients who have
undergone conversion from EA to GA are considered
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Table IV. Operative and perioperative data of 115 patients (on-treatment univariate analysis)
Epidural anesthesia (n = 58) General anesthesia (n = 57) P value
Mean operating time (minutes) 120 130 .7
Mean contrast agent (mL) 153 164 .5
Mean fluoro time (minutes) 20.6 23.1 .5
Mean blood loss (mL) 246 323 .3
Mean units of transfused blood 0.05 0.35 .02
Patients transferred to ICU 0 5 .027
Mean postoperative stay (days) 2.5 3.2 .04
Proximal cuffs 4 4 1
Postoperative endoleaks 9 9 .8
Graft-related endoleaks at 30 days 2 4 .4
ICU, Intensive care unit.
as if they underwent the procedure with EA. These
figures imply that EA is not always feasible and sug-
gest that it is not the intention to use EA, but the suc-
cessful completion of a case with the use of EA that is
associated with reduced length of hospitalization.
The advantages of EA should be taken into
account. In our series, patients operated on with EA
had an overall performance superior to patients oper-
ated on with GA. EA was associated with no need of
intensive care unit, significantly fewer transfusions
(although it is unlikely that transfusions were influ-
enced by the type of anesthesia), and a significantly
shorter hospital stay, the variable most frequently
used to assess recovery. Considering the hypothesis
that benefits of EA could be related to better experi-
ence, we eliminated the first 15 patients when con-
ducting the analysis, because in these patients the
possibility of performing EA was not considered.
Our findings about the mean length of hospitaliza-
tion and need to stay in the intensive care unit were
basically confirmed.
Chumbley and Hall reported that the type of
anesthesia has only a minor role in enhancing recov-
ery and that changes in surgical technique have been
more productive.18 When this theory is applied to
AAA surgery, most surgeons would agree that the
duration of hospital stay is shorter when aneurysms
are repaired by means of endoluminal techniques than
by means of laparotomy. Although it certainly has a
less dramatic impact, a reduction in length of hospi-
talization for patients undergoing EAAR with EA
compared with patients undergoing EAAR with GA is
appealing, especially when considering that presently
the endovascular procedure is much more expensive
than the standard surgical operation. Costs were not
analyzed in the present study, but it is reasonable to
speculate that the use of EA saves costs, compared
with the use of GA in endovascular surgery for AAA.
In a recent review, Holzenbein et al19 showed that
endovascular procedures save costs, compared with
conventional treatment. According to that analysis,
the difference in expenses was related to the decreased
length of hospital and intensive care unit stay, which
compensated for the high costs of the endovascular
equipment. In the present series, transfer to the inten-
sive care unit was caused in most cases by the difficul-
ty in weaning patients undergoing tracheal intuba-
tion, and therefore was related, at least in part, to the
type of anesthesia. Likewise, the length of hospital
stay was significantly longer in group B.
A satisfactory experience with the use of EA for
EAAR has been reported by Aadahl et al, who ana-
lyzed the effect of EA on arterial blood pressure and
recovery and concluded that EA is feasible, effective,
and safe. Yet, this study included only 21 patients
and lacked a control group.1
In patients undergoing vascular surgery, EA has
been associated with reduced incidence of periopera-
tive myocardial infarction and mortality, reduced
postoperative pulmonary complications, faster recov-
ery of gastrointestinal function, and better peripheral
vascular circulation.20 On the other hand, Bode et al,
who reported the results of a prospective randomized
trial examining the impact of type of anesthesia on
cardiac outcome in patients undergoing peripheral
vascular surgery, found that the type of anesthesia
does not significantly influence cardiac morbidity and
overall mortality.21 Other studies failed to demon-
strate the superiority of EA in patients undergoing
vascular surgery.22,23 Although a limitation of our
study is the lack of randomization, patients were well
balanced in the two study groups, making it possible
to elaborate on some considerations. Outcome mea-
sures analyzed in our surgically oriented study, such as
mean surgical and fluoro time, blood loss, and the
amount of contrast media used in our two study
groups, although not significant from a statistical
standpoint, were higher in the group undergoing
surgery with GA. Conversion from EA to GA was
necessary only in three of 61 patients, an expression of
the high feasibility of the technique. Based on the data
we have presented, the sample size for a prospective
randomized study on the impact of EA on hospital-
ization should be approximately 500 patients.
Possible shortcomings of EA, such as epidural
hematoma, occurrence of severe hypotension, or
additional time to perform regional block, should
also be acknowledged, but were not documented in
our experience. 
Our data suggest a satisfactory performance of
EA in endoluminal aortic replacement and support
the continued use of EA. Patients who successfully
completed EAAR with EA had a quicker recovery
than patients undergoing EAAR with GA. Patient
anxiety was the cause of conversion from EA to GA
in most cases. Data from a large-scale, randomized,
prospective study analyzing selected groups of
patients and well-defined anesthetic techniques are
needed to conclusively establish the role of EA in
endoluminal aortic surgery.
We thank Dr Stefano Ricci for invaluable assistance
with statistical analysis.
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